ConductScience.org, home
LAMA2: laminin subunit alpha 2
API referenceFor AI assistants

Gene · 3908

Papers2,255

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 2,255

Download this page as JSON
TitleJournalYearPMIDFound bySource
Conserved neuronal-like and secretory programs define the spatial architecture of gastroenteropancreatic neuroendocrine tumors.J Clin Invest202642678737PubTator, text miningPubMed
Nanofibrous Matrices Modulating Glioma Cell Migration and Proliferation and the Exploration of Their Molecular Mechanism.ACS Appl Bio Mater202642606053PubTator, text miningPubMed
Triple-AAV intein-mediated gene therapy ameliorates dystrophic phenotype in MDC1A mice.Mol Ther202642528140PubTator, text miningPubMed
Integrative multi-omics analysis identifies stellate cell-derived complement component 7 as a predictor of fibrosis and liver-related events in MASLD.JHEP Rep202642486350PubTator, text miningPubMed
Cause of a fatal multi-organ fat embolism syndrome in a patient with LAMA2-associated congenital muscular dystrophy.Forensic Sci Med Pathol202642390674PubTator, text miningPubMed
Polymerizing laminins: Assembly, functions and disorders.Matrix Biol202642349693PubTator, text miningPubMed
Comments on the "Unexplained multiorgan fat embolism syndrome in a 10-year-old child with LAMA2-related congenital muscular dystrophy", and on the subsequent correspondence.Forensic Sci Med Pathol202642319696PubTator, text miningPubMed
Gene-Environment Interaction Loci Associated with Refractive Error: SCAMPI Analysis.Ophthalmol Sci202642293346PubTator, text miningPubMed
The Effect of Trunk Brace Use on Motor and Pulmonary Functions in a Patient with LAMA2-Related Congenital Muscular Dystrophy: A Case Report.Stud Health Technol Inform202642290440PubTator, text miningPubMed
The Proliferation and Adipogenic/Fibrogenic Fate Commitment of FAPs via an Autocrine LAMA2/ITGβ1-FAK Pathway.J Agric Food Chem202642267524PubTator, text miningPubMed
Comments on: unexplained multiorgan fat embolism syndrome in a 10-year-old child with LAMA2-related congenital muscular dystrophy.Forensic Sci Med Pathol202642258044PubTator, text miningPubMed
Expanding the Utility of Exome Sequencing in Preventive and Population Genetics.Am J Med Genet A202642212615PubTator, text miningPubMed
Unexplained multiorgan fat embolism syndrome in a 10-year-old child with LAMA2-related congenital muscular dystrophy.Forensic Sci Med Pathol202642189382PubTator, text miningPubMed
Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease.Hum Mol Genet202642165280PubTator, text miningPubMed
Neuromuscular Disorders in Children Through the Lens of Next-Generation Sequencing: A Study of Diagnostic Yield.Int J Mol Sci202642123532PubTator, text miningPubMed
Expanding the genetic spectrum of neurogenetic disorders in moroccan families by exome sequencing: identification of candidate variants in RYR3, POLR3A, and LAMA2.Mol Biol Rep202642113100PubTator, text miningPubMed
Gold nanoparticle-based electrophoresis-free colorimetric detection method for allele-specific PCR-SNP genotyping.Anal Biochem202642082012PubTator, text miningPubMed
Congenital Myopathies and Muscular Dystrophies: A Single Tertiary Center Experience and Factors Associated With Long-Term Outcomes.Muscle Nerve202642036360PubTator, text miningPubMed
Mature Schwann Cells Derived From Human Induced Pluripotent Stem Cells Promote Peripheral Nerve Regeneration In Vivo.Neurosci Insights202642022573PubTator, text miningPubMed
A molecular makeover of laminin-α4 with linker proteins to mimic the function of laminin-α2 for the treatment of LAMA2-CMD.Mol Ther202641990749PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3908/papers

API referenceFor AI assistants